Document is current

Article History

Received: 13 June 2023

Revised: 7 May 2024

Accepted: 8 May 2024

First Online: 24 July 2024

Declarations

: This prospective trial was approved by the local Ethics Committee (approval number: 2022-638-Art.82 MDR / 15 BO) of the University Frankfurt, Germany, and followed the tenets of the Declaration of Helsinki.

: Informed consent was given prior to including patients to the trial. All patients signed an informed consent form before any trial specific measurements were conducted.

: T. Kohnen: Consultant and Research for Alcon/Novartis, J&J, Lensgen, Oculentis, Oculus, Presbia, Schwind, Zeiss. Consultant for Allergan, Bausch & Lomb, Geuder, Med Update, Santen, Staar, Thieme, Zieme. All other authors have no financial interests to declare.